G. Aygun, O. Kayhan, Fatouma Moustapha Houssein, S. Urkmez, A. Kurt, B. Mete
{"title":"受污染的非批准仿制瑞德西韦小瓶:治疗COVID-19的新风险","authors":"G. Aygun, O. Kayhan, Fatouma Moustapha Houssein, S. Urkmez, A. Kurt, B. Mete","doi":"10.36519/idcm.2020.0031","DOIUrl":null,"url":null,"abstract":"The original trademark name of remdesivir with proven and approved efficacy developed by Gilead is Veklury®. Veklury® is licenced in over 50 countries around the world, including the United States, European Union, Japan, Canada, Australia. Veklury® has not yet been licenced by the Ministry of Health in Turkey. Gilead supplied 17 378 vials of Veklury® to the Health of Ministry of Turkey free of charge. However, Gilead announced that illegal products which are likely to contain remdesivir have been entered our country and sold on the black market (3).","PeriodicalId":11964,"journal":{"name":"European Journal of Clinical Microbiology and Infectious Diseases","volume":"31 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Contaminated Generic Non-approved Remdesivir Vials: New Risk in Treatment of COVID-19\",\"authors\":\"G. Aygun, O. Kayhan, Fatouma Moustapha Houssein, S. Urkmez, A. Kurt, B. Mete\",\"doi\":\"10.36519/idcm.2020.0031\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The original trademark name of remdesivir with proven and approved efficacy developed by Gilead is Veklury®. Veklury® is licenced in over 50 countries around the world, including the United States, European Union, Japan, Canada, Australia. Veklury® has not yet been licenced by the Ministry of Health in Turkey. Gilead supplied 17 378 vials of Veklury® to the Health of Ministry of Turkey free of charge. However, Gilead announced that illegal products which are likely to contain remdesivir have been entered our country and sold on the black market (3).\",\"PeriodicalId\":11964,\"journal\":{\"name\":\"European Journal of Clinical Microbiology and Infectious Diseases\",\"volume\":\"31 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-12-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Clinical Microbiology and Infectious Diseases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.36519/idcm.2020.0031\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Clinical Microbiology and Infectious Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36519/idcm.2020.0031","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Contaminated Generic Non-approved Remdesivir Vials: New Risk in Treatment of COVID-19
The original trademark name of remdesivir with proven and approved efficacy developed by Gilead is Veklury®. Veklury® is licenced in over 50 countries around the world, including the United States, European Union, Japan, Canada, Australia. Veklury® has not yet been licenced by the Ministry of Health in Turkey. Gilead supplied 17 378 vials of Veklury® to the Health of Ministry of Turkey free of charge. However, Gilead announced that illegal products which are likely to contain remdesivir have been entered our country and sold on the black market (3).
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
